Salinas J, Bello B, Antúnez C, De Nordenflycht D. Flawed prosthodontic treatment as a triggering factor of orofacial dyskinesia: A case report. J Clin Exp Dent. 2024;16(6):e785-8.

doi:10.4317/jced.61635

https://doi.org/10.4317/jced.61635

______

References

1. Blanchet PJ, Rompré PH, Lavigne GJ, Lamarche C. Oral dyskinesia: a clinical overview. Int J Prosthodont. 2005;18:10-9.

2. Clark GT, Ram S. Orofacial Movement Disorders. Oral Maxillofac Surg Clin North Am. 2016;28:397-407.
https://doi.org/10.1016/j.coms.2016.03.003
PMid:27475514

3. Tschopp L, Salazar Z, Micheli F. Botulinum toxin in painful tardive dyskinesia. Clin Neuropharmacol. 2009;32:165-6.
https://doi.org/10.1097/WNF.0b013e31818ddbc4
PMid:19483486

4. Emami E, de Souza RF, Kabawat M, Feine JS. The impact of edentulism on oral and general health. Int J Dent. 2013;2013:498305.
https://doi.org/10.1155/2013/498305
PMid:23737789 PMCid:PMC3664508

5. Blanchet PJ, Abdillahi O, Beauvais C, Rompré PH, Lavigne GJ. Prevalence of spontaneous oral dyskinesia in the elderly: a reappraisal. Mov Disord. 2004;19:892-6.
https://doi.org/10.1002/mds.20130
PMid:15300653

6. Balasubramaniam R, Ram S. Orofacial movement disorders. Oral Maxillofac Surg Clin North Am. 2008;20:273-85, vii.
https://doi.org/10.1016/j.coms.2007.12.010
PMid:18343330

7. Ghadery CM, Kalia LV, Connolly BS. Movement disorders of the mouth: a review of the common phenomenologies. J Neurol. 2022;269:5812-30.
https://doi.org/10.1007/s00415-022-11299-1
PMid:35904592

8. Girard P, Monette C, Normandeau L, Pampoulova T, Rompré PH, de Grandmont P, et al. Contribution of orodental status to the intensity of orofacial tardive dyskinesia: an interdisciplinary and video-based assessment. J Psychiatr Res. 2012;46:684-7.
https://doi.org/10.1016/j.jpsychires.2012.02.003
PMid:22386652

9. Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol. 2014;13:100-12.
https://doi.org/10.1016/S1474-4422(13)70213-8
PMid:24331796

10. Chen S, Kim JJP, Barbieri JT. Mechanism of substrate recognition by botulinum neurotoxin serotype A. J Biol Chem. 2007;282:9621-7.
https://doi.org/10.1074/jbc.M611211200
PMid:17244603

11. Hok P, Veverka T, Hluštík P, Nevrlý M, Kaňovský P. The Central Effects of Botulinum Toxin in Dystonia and Spasticity. Toxins. 2021;13.
https://doi.org/10.3390/toxins13020155
PMid:33671128 PMCid:PMC7922085

12. Yoshida K. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System. Toxins. 2022;14.
https://doi.org/10.3390/toxins14040282
PMid:35448891 PMCid:PMC9026473